US fusion strategy stuck in past as China moves ahead, CEO warns

Commonwealth Fusion Systems CEO Bob Mumgaard warns the U.S. risks falling behind China in the emerging commercial fusion sector, noting Beijing-backed initiatives such as China Fusion Energy Co. Ltd (CFEC) with 15 billion yuan (~$2.1bn) registered capital and estimated Chinese investment of $6–$12 billion in recent years. Mumgaard highlights more than $10 billion of private capital in global fusion companies and points to CFS’s SPARC program and a planned grid-scale plant in Chesterfield County, Virginia, targeting the early 2030s as proof points of private-sector progress. He argues U.S. government structures and programs remain outdated and urges public‑private collaboration models to accelerate deployment and secure technological leadership.

Analysis

Market structure: Fusion’s maturation (China deploying $6–$12B in test stands; >$10B private capital globally) creates a long runway of winners in enabling technologies (high‑temperature superconductors, cryogenics, industrial gases, grid interconnect) and losers among legacy fuel exporters if commercialization accelerates past 2030. Expect early concentration benefits to specialist suppliers (pricing power for HTS wire & magnet manufacturers) rather than utilities or integrated oil producers in the near term; commercial power pricing impacts are likely muted until 2030–2035 when first plants could reach scale.

Risk assessment: Tail risks include a catastrophic experiment failure, IP expropriation by state actors, or US export controls that fragment supply chains—each could wipe out valuations for specialist public suppliers (20–50% downside scenarios). Time horizons: days–months — limited news-driven volatility; 6–24 months — funding rounds, government policy shifts and key demos (SPARC milestones) matter; 3–10 years — structural demand effects on commodities and baseload pricing. Hidden dependencies: rare earths/yttrium, helium and Chinese manufacturing for critical components create single‑point supply risks.

Trade implications: Implement concentrated, asymmetric exposures to enablers rather than utilities: long HTS and cryogenics suppliers, long copper/miners for electrification, and tactical options to express binary demo risk (buy LEAPS calls on enablers, sell shorter calls to fund). Pair trades (long specialist supplier, short utility ETF XLU) hedge macro power‑price cyclicality; use 12–36 month horizons and size at 1–4% portfolio each. Key catalysts to watch: successful net‑gain demo, new US federal fusion program funding (> $5B commitment), major Chinese commercial plant announcements.

Contrarian angles: Consensus that US is categorically behind ignores pockets of US tech leadership (HTS magnets, AI+controls) and deep private capital; public markets likely underprice these niches. The market may be overreacting to geopolitics (moving capital into megadefense plays) and underreacting to supply‑chain winners — look for mispricings in small‑cap enablers where 1 successful contract (>$100M) could re-rate multiples by 2–3x. Historical parallel: space race — government panic led to outsized returns for a few private contractors; fusion will likely mirror that pattern.

Key Decisions for Investors

• Establish a 2–3% long position in American Superconductor (AMSC) over 12–36 months to play HTS magnet demand; prefer buying shares or buying 24–36 month LEAPS calls (buy Jan 2027 $20–$30 strikes if available).
• Allocate 2% to industrial gases/cryogenics leaders (Linde PLC, LIN) for 12–24 months exposure to helium/cryogenics demand; buy shares or 12–18 month call spreads (debit call spread 10–20% OTM) to limit capital at risk.
• Add 2–3% long exposure to copper via Freeport‑McMoRan (FCX) or a bullion‑style copper ETF for a 2–5 year horizon to capture electrification tailwinds; use a 25% trailing stop or hedge with 12–18 month put protection if price rallies >30%.
• Initiate a hedge pair: long 1–2% AMSC (or LIN) vs short equal notional XLU (Utilities ETF) sized to net zero delta; horizon 6–24 months to capture relative performance if fusion enabling tech rerates versus regulated utilities.
• Use options to express binary upside: purchase 24–36 month LEAPS calls on a chosen enabler (AMSC or LIN) sized 0.5–1% premium of portfolio and fund by selling 3–6 month covered calls or put spreads; accelerate buys if SPARC/net‑gain demo occurs within 12 months or if US federal funding >$5B is announced.